Specifically, high levels of CDK4 were observed in glioma tissues, and the inhibitors of CDK4/6 block cell proliferation, induced apoptosis, and enhanced the cell sensitivity to temozolomide in glioma patients [32]. This evidence concerns the gene CDK4 and glioma.